As Professor of Oncology Mikhail Blagosklonny has his own take on the best approach to adopt. Currently working as a professor of oncology at the Roswell Park Cancer Institute, Blagosklonny is internationally renowned for his work on cancer and the aging phenomenon. He is an MD in medicine from the First Pavlov State Medical University of St. Petersberg. From the same University, he also earned a Ph.D. in experimental medicine and cardiology.
In the year 2002, he was made associate professor of medicine at New York Medical College, Valhalla. Post that he served was at Ordway Research Institute. It was in 2009 that he finally made it to Roswell Park as professor of oncology. His varied experience meant that he became an outstanding professor in his field of specialization. Read more on Healing Magic
Among his foremost research interests are biogerontology, anti-aging and cancer drugs and specific cancer therapies that protect healthy cells from harm. Apart from the above, he also works in the capacity of editor-in-chief of Oncotarget and Cell Cycle. Other than holding these positions he also happens to be the editor of Cancer Biology and Therapy. That’s not all. Blagosklonny is on the Cell Death and Differentiation editorial board.
Among his sterling contributions to medical science has been the propounding of the idea that supports the role of well known cancer drug rapamycin as a means of extending life. He has based this on extensive research that he has carried out on the subject that encompasses cellular and microbiology to clinical investigations. In the main, it comprises of signal transduction , ontogenesis, tumor suppressors and drug resistance of normal cells among other things.
Apart from all of the above Blagosklonny is an author of the aging hyperfunction theory. In addition to that, he is known to write about cell cyclotherapy and chemotherapeutic engineering. Blagosklonny above all is a keen believer that both cancer and aging can be checked. That is a major reason for him to advocate the use of rapamycin aggressively.
With more than 300 research articles, books chapters and reviews published under his name Mikhail Blagosklonny is definitely a highly respected authority in the field of medical sciences. Moreover, he has other feathers in his cap like associate editorship of PLOS ONE, the American Journal of Pathology and the International Journal of Cancer. If today Blagosklonny is one of the world’s foremost oncology researchers, it is because of the tremendous amount of hard work he has put into it. View his LinkedIn profile
This is possible only if one has the passion to not only excel in any field but for also serving others through it. Blagosklonny firmly believes that it is his vision and passion to see a disease free world that makes him work as hard as he does. It is always pioneers like him, whose fierce passion for something they believe in from the innermost recesses of their heart, who make discoveries that change the course of the world. Blagoklonny is surely one of those. The coming times will see him get vindicated even more emphatically than he already has been.